Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The study findings indicate that about 25% of patients with breast symptoms had a delay of more than three months before presenting to a health professional. This finding is comparable with other studies. Recent studies have shown a range of 19% to 32% for patient delay [1,3,4,12,13]. However the extent of patient delay can be different in different places. One explanation for such a difference might relate to the patients' health related behaviors and the social context they live in. It is argued that an intention to seek evaluation of breast symptoms is not merely a matter of education and economics but it is dependent on a complex picture of personal. | Focus on CME at Memorial University of Newfoundland New Developments in Upper and Lower Genital Tract Cancer Unique to the gynecologic cancers are the direct elements of sexuality fertility and femininity. The family physician is integral to helping patients navigate their journey through this difficult time of not only life and death but identity. By Catherine Popadiuk MD Presented at CME Gynecologic Oncology Pot Pourri Burin Newfoundland June 2000 Dr. Popadiuk is assistant professor and gynecologic oncologist department of obstetrics and gynecology Memorial University St. John s Newfoundland. She also is cochair Memorial University Human Investigation Committee. This review will examine simple principles and guidelines to help the family physician integrate important concepts and heighten awareness regarding new developments and controversies in lower and upper genital tract cancer. We will focus on the concepts of screening and prevention and clinical presentation and provide guidance as to what to expect when the patient goes through the diagnosis and treatment The Canadian Journal of CME April 2001 137 Gynecologic Cancer Table 1 Canadian Cancer Statistics Table 2 Cervical Cancer Risk Factors Type Prevalence Deaths Breast 19 200 5 500 Lung 8 400 7 000 Colorectal 7 900 3 000 Uterus 3 500 670 Ovary 2 500 1 500 Pancreas 1 600 1 500 Cervix 1 450 430 Not having a Pap smear Early onset of sexual activity Multiple sexual partners Exposure to high-risk male partners Human immunodeficiency virus infection Increased age Lower socioeconomic status Smoking Controversial dietary deficiencies vitamin A Oral contraceptive pill of gynecologic malignancy. Breast cancer as the most prevalent cancer affecting one in nine women is a good point of comparison. In contrast the most common gynecologic malignancies such as endometrial ovarian and cervical cancer affect one in 37 one in 70 and one in 100 women respectively.1 The remaining gynecologic cancers vulva vagina and fallopian .
